Find a Tender · Contract

Cell-based Quadrivalent Influenza Vaccine

A public procurement published by The Common Services Agency (more commonly known as NHS National Services Scotland) ("NSS") via Find a Tender.

Find a TenderContract
Award value
Tender value
1
Suppliers
2
Awards
2
Notices
Contract
Stage

Overview

This procurement is for the supply of cell-based quadrivalent influenza vaccine to NHSScotland for use in the annual seasonal influenza immunisation programme.

Key details

Source
Find a Tender
Lifecycle stage
Contract
Status
complete
CPV classification
33651660 — Influenza vaccines
Currency
GBP
Total award value
Tender value
First published
9 Apr 2021
Last updated
29 Apr 2021
View the original notice

Awards

2 awards recorded on this procurement.

SupplierCompanies HouseAwardedStatusValue
Seqirus UK Limited09614642active
Seqirus UK Limited09614642active

Notice timeline

Every published notice in this procurement's lifecycle.

  1. Award,contractCell-based Quadrivalent Influenza Vaccine
  2. Award,contractCell-based Quadrivalent Influenza Vaccine

All suppliers

Frameworks & programmes

More from The Common Services Agency (more commonly known as NHS National Services Scotland) ("NSS")

FAQs about this procurement

Who is the buyer for "Cell-based Quadrivalent Influenza Vaccine"?

Cell-based Quadrivalent Influenza Vaccine is a UK public-sector procurement published by The Common Services Agency (more commonly known as NHS National Services Scotland) ("NSS") via Find a Tender.

Has "Cell-based Quadrivalent Influenza Vaccine" been awarded?

Yes — 2 awards are recorded. The current lifecycle stage is "Contract".

Which suppliers are involved in "Cell-based Quadrivalent Influenza Vaccine"?

1 supplier is linked: Seqirus UK Limited.

When was "Cell-based Quadrivalent Influenza Vaccine" published?

It was first published on 9 Apr 2021 and last updated on 29 Apr 2021, across 2 notices.

Track procurements like this one

Enable monitors the entire UK public-contract pipeline — get alerts on buyers, suppliers and frameworks that matter to you.

Get in touch with Enable